BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
0.601
0.00 (0.00%)
At close: Apr 28, 2026

BFNH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-1.29-0.49-0.47-0.49-0.5
Upgrade
Other Operating Activities
0.8----
Upgrade
Change in Accounts Payable
00.010-0.010
Upgrade
Change in Other Net Operating Assets
0.420.420.420.420.42
Upgrade
Operating Cash Flow
-0.07-0.06-0.05-0.07-0.08
Upgrade
Short-Term Debt Issued
0.070.050.050.060.05
Upgrade
Total Debt Issued
0.070.050.050.060.05
Upgrade
Net Debt Issued (Repaid)
0.070.050.050.060.05
Upgrade
Issuance of Common Stock
-0.01-0-
Upgrade
Financing Cash Flow
0.070.060.050.060.05
Upgrade
Net Cash Flow
-00-0-0.01-0.03
Upgrade
Levered Free Cash Flow
-1.820.120.130.110.11
Upgrade
Unlevered Free Cash Flow
-1.820.120.130.110.11
Upgrade
Change in Working Capital
0.420.430.430.420.42
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.